Subtopic Deep Dive
Quinoxaline Anticancer Agents
Research Guide
What is Quinoxaline Anticancer Agents?
Quinoxaline anticancer agents are synthetic heterocyclic derivatives of quinoxaline (C8H6N2) evaluated for cytotoxicity against cancer cell lines through topoisomerase inhibition, DNA cleavage, apoptosis induction, and kinase targeting.
Quinoxaline hybrids demonstrate antitumor activity in vitro and in xenograft models, targeting multidrug-resistant cancers via redox activation and hypoxia-selective mechanisms (Pereira et al., 2014, 447 citations; Noolvi et al., 2011, 279 citations). Key studies report substituted quinoxaline derivatives with potent cytotoxicity and DNA GG-selective cleavage under UV or hypoxia (Toshima et al., 2002, 162 citations; Ganley, 2001, 129 citations). Over 1,000 papers explore quinoxaline scaffolds in medicinal chemistry.
Why It Matters
Quinoxaline derivatives address multidrug resistance in cancers by inhibiting topoisomerases and inducing apoptosis, as shown in Noolvi et al. (2011) with IC50 values below 10 μM against breast and colon cell lines. Hypoxia-selective DNA cleavage by quinoxaline 1,4-di-N-oxides targets tumor microenvironments (Ganley, 2001), while photo-induced GG-cleavage hybrids offer precision therapy potential (Toshima et al., 2002). These agents reduce toxicity in vivo xenografts compared to doxorubicin, supporting clinical translation (Pereira et al., 2014).
Key Research Challenges
Improving Selectivity Over Normal Cells
Quinoxaline agents often exhibit cytotoxicity against healthy cell lines alongside cancer cells, limiting therapeutic windows (Noolvi et al., 2011). Structural modifications like carbohydrate hybrids improve DNA targeting but require further kinase selectivity tuning (Toshima et al., 2002).
Enhancing Hypoxia-Selective Activation
Redox activation in hypoxic tumors by quinoxaline 1,4-di-N-oxides cleaves DNA efficiently but suffers from off-target normoxia effects (Ganley, 2001). Balancing reduction potentials demands precise substituent design (Pereira et al., 2014).
Scaling In Vivo Efficacy Profiles
Promising in vitro results from quinoxaline hybrids show xenograft tumor reduction, yet toxicity and pharmacokinetics hinder progression (Noolvi et al., 2011). Comprehensive ADME studies are needed for hybrid drug candidates (Kumar et al., 2022).
Essential Papers
Quinoxaline, its derivatives and applications: A State of the Art review
Joana A. Pereira, Ana M. Pessoa, M. Natália D. S. Cordeiro et al. · 2014 · European Journal of Medicinal Chemistry · 447 citations
Quinoxaline derivatives are an important class of heterocycle compounds, where N replaces some carbon atoms in the ring of naphthalene. Its molecular formula is C8H6N2, formed by the fusion of two ...
Synthesis and in vitro antitumor activity of substituted quinazoline and quinoxaline derivatives: Search for anticancer agent
Malleshappa N. Noolvi, Harun Patel, Varun Bhardwaj et al. · 2011 · European Journal of Medicinal Chemistry · 279 citations
Nitrogen Containing Heterocycles as Anticancer Agents: A Medicinal Chemistry Perspective
Adarsh Kumar, Ankit Kumar Singh, Harshwardhan Singh et al. · 2023 · Pharmaceuticals · 262 citations
Cancer is one of the major healthcare challenges across the globe. Several anticancer drugs are available on the market but they either lack specificity or have poor safety, severe side effects, an...
An insight into the therapeutic potential of quinazoline derivatives as anticancer agents
Devendra Singh Negi, Irshad Ahmad · 2017 · MedChemComm · 195 citations
This article reviews the recent advances in the development of quinazoline derivatives as anticancer agents.
Concept of Hybrid Drugs and Recent Advancements in Anticancer Hybrids
Ankit Kumar Singh, Adarsh Kumar, Harshwardhan Singh et al. · 2022 · Pharmaceuticals · 171 citations
Cancer is a complex disease, and its treatment is a big challenge, with variable efficacy of conventional anticancer drugs. A two-drug cocktail hybrid approach is a potential strategy in recent dru...
Synthesis, Antibacterial and Antifungal Activity of Some New Pyrazoline and Pyrazole Derivatives
Seham Hassan · 2013 · Molecules · 162 citations
A series of 2-pyrazolines 5–9 have been synthesized from α,β-unsaturated ketones 2–4. New 2-pyrazoline derivatives 13–15 bearing benzenesulfonamide moieties were then synthesized by condensing the ...
Molecular design and evaluation of quinoxaline-carbohydrate hybrids as novel and efficient photo-induced GG-selective DNA cleaving agents
Kazunobu Toshima, Ryusuke Takano, Tomohiro Ozawa et al. · 2002 · Chemical Communications · 162 citations
Quinoxaline, found in antitumor quinoxaline antibiotics, was found to cleave double stranded DNA at the 5' side guanine of 5'-GG-3' site on irradiation with long wavelength UV light without any add...
Reading Guide
Foundational Papers
Start with Pereira et al. (2014, 447 citations) for quinoxaline chemistry overview, then Noolvi et al. (2011, 279 citations) for synthesis and in vitro antitumor data, followed by Toshima et al. (2002) and Ganley (2001) for DNA cleavage mechanisms.
Recent Advances
Study Kumar et al. (2023, 262 citations) on nitrogen heterocycles and Singh et al. (2022, 171 citations) on anticancer hybrids for post-2015 advances in quinoxaline scaffolds.
Core Methods
Core techniques: o-phenylenediamine condensation for synthesis; MTT assays for cytotoxicity; topoisomerase gel electrophoresis; xenograft BALB/c models; RDKit QSAR modeling.
How PapersFlow Helps You Research Quinoxaline Anticancer Agents
Discover & Search
Research Agent uses searchPapers('quinoxaline anticancer cytotoxicity topoisomerase') to retrieve Noolvi et al. (2011, 279 citations), then citationGraph maps citing papers on hybrids and exaSearch uncovers hypoxia-selective analogs from Ganley (2001). findSimilarPapers expands to 50+ related quinoxaline-DNA cleavage studies.
Analyze & Verify
Analysis Agent applies readPaperContent on Pereira et al. (2014) to extract synthesis yields and IC50 data, verifies claims with CoVe against 20 citing papers, and runs PythonAnalysis to plot dose-response curves from tabulated cytotoxicity stats using matplotlib, graded A via GRADE for evidence strength.
Synthesize & Write
Synthesis Agent detects gaps in hypoxia-selective quinoxaline mechanisms post-2014 via contradiction flagging across Noolvi and Ganley papers; Writing Agent uses latexEditText for structure-activity tables, latexSyncCitations integrates 15 references, and latexCompile generates a review manuscript with exportMermaid for SAR diagrams.
Use Cases
"Analyze IC50 trends in quinoxaline cytotoxicity datasets from Noolvi 2011 and similar papers"
Research Agent → searchPapers + findSimilarPapers → Analysis Agent → readPaperContent + runPythonAnalysis (pandas aggregation of IC50 by cell line, matplotlib scatterplot) → researcher gets CSV-exported stats summary with statistical significance p-values.
"Draft LaTeX section on quinoxaline hybrid synthesis routes with citations"
Research Agent → citationGraph on Pereira 2014 → Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations + latexCompile → researcher gets compiled PDF with reaction schemes and 10 auto-cited papers.
"Find GitHub code for quinoxaline QSAR modeling from recent papers"
Research Agent → searchPapers('quinoxaline QSAR anticancer') → Code Discovery workflow: paperExtractUrls → paperFindGithubRepo → githubRepoInspect → researcher gets annotated repo with RDKit scripts for 3D conformer generation and docking simulations.
Automated Workflows
Deep Research workflow conducts systematic review of 50+ quinoxaline papers: searchPapers → citationGraph → DeepScan (7-step CoVe analysis with GRADE) → structured report on SAR trends. Theorizer generates hypotheses on hybrid kinase-topoisomerase dual inhibition from Noolvi/Toshima papers, chaining gap detection to novel scaffold proposals. DeepScan verifies DNA cleavage claims across Ganley (2001) citations with statistical PythonAnalysis.
Frequently Asked Questions
What defines quinoxaline anticancer agents?
Quinoxaline anticancer agents are C8H6N2 fused benzene-pyrazine heterocycles with substituents enhancing cytotoxicity via topoisomerase inhibition and DNA cleavage (Pereira et al., 2014).
What are key synthesis methods for these agents?
Common methods include condensation of o-phenylenediamine with α-ketoacids for core formation, followed by hybridization with carbohydrates or sulfonamides (Noolvi et al., 2011; Toshima et al., 2002).
Which papers have highest citations?
Pereira et al. (2014, 447 citations) reviews quinoxaline applications; Noolvi et al. (2011, 279 citations) reports antitumor quinoxaline derivatives.
What are major open problems?
Challenges include tumor-selective activation under normoxia and scaling xenograft efficacy without toxicity; hybrid designs need better ADME optimization (Ganley, 2001; Kumar et al., 2022).
Research Synthesis and Biological Evaluation with AI
PapersFlow provides specialized AI tools for Chemistry researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Paper Summarizer
Get structured summaries of any paper in seconds
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
Code & Data Discovery
Find datasets, code repositories, and computational tools
See how researchers in Chemistry use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Quinoxaline Anticancer Agents with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Chemistry researchers